Cassava Sciences IncEquity-NMS: SAVA
Equity-NMS: SAVA
$23
+0.02
(3 Mar)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$23.00
Open
$23.00
Today’s high
$23.28
Today’s low
$22.81
52W low
$12.32
52W high
$32.1
1Y
-13.21%
5Y
80.40%
Shares O/S
43.23M
Market cap
994.18M
Insights
SAVA price is above its 200 day moving average
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Cassava Sciences Inc

Cassava Sciences, Inc. is a clinical-stage biotechnology company. The Company is engaged in the detection and treatment of neurodegenerative diseases, such as Alzheimer’s disease. The Company develops pharmaceutical product candidates that offer improvements to patients and healthcare professionals. The Company has two biopharmaceutical assets under development, including its lead therapeutic product candidate, called simufilam, is an oral treatment for Alzheimer’s disease dementia, which is under Phase III clinical studies; and its lead investigational diagnostic product candidate, called SavaDx, is a way to detect the presence of Alzheimer’s disease from a small sample of blood.

Simufilam is a proprietary small molecule (oral) drug, which targets an altered form of a protein called filamin A (FLNA) in the Alzheimer’s brain. SavaDx is designed as an antibody-based detection system for altered filamin A (FLNA). .


FAQs

Can I buy Cassava Sciences Inc shares in India?
How to buy Cassava Sciences Inc shares in India?
What is the share price of Cassava Sciences Inc?
What is the Market Capitalization of Cassava Sciences Inc?
What is the PE ratio of Cassava Sciences Inc?
Is Cassava Sciences Inc a good stock to buy?
In which sector / industry does Cassava Sciences Inc operate?